Zydus launches Lenalidomide capsules

Zydus Lifesciences has launched Lenalidomide capsules in the US. The company had earlier received final approvals for 5 mg, 10 mg, 15 mg and 25 mg strengths and tentative approvals for 2.5 mg and 20 mg strength, a company statement notified.

Lenalidomide is used to treat various types of cancers. It works by slowing or stopping the growth of cancer cells. It is also used to treat anaemia in patients with certain blood/bone marrow disorders. The drug is being manufactured at the group’s formulation manufacturing facility at Ahmedabad SEZ, India, the statement added.